Skip to main content
Mon, Apr 6, 2026
TrendingNews.today
World News
S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|
S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|
Sample data
General1 sourcesNeutral

Actinium Pharmaceuticals Announces New Pan-Tumor Preclinical Data For ATNM-400 In Solid Tumors And Differentiated Mechanism For Actimab-A In AML To Be Presented At 2026 AACR Annual Meeting

(MENAFN - PR Newswire) New data underscoring the potential of ATNM-400 as a first-in-class Ac-225 radioconjugate with broad pan-tumor efficacy across multiple solid tumor models Actimab-A ...

Menafn
via Menafn
ShareRead original

Read the full article at Menafn →

Actinium Pharmaceuticals Announces New Pan-Tumor Preclinical Data For ATNM-400 In Solid Tumors And Differentiated Mechanism For Actimab-A In AML To Be Presented At 2026 AACR Annual Meeting

Source Verification

Corroboration Score: 1

This story was independently reported by 1 sources. Click any source to read the original article.

Menafn
Menafn
NewsData

Comments

0 comments
Be respectful and constructive.
Loading comments...
Previous
Digital replicas can help doctors treat heart issues
Next
Dear Abby: My neurological disorder has made maintaining friendships impossible

Related Articles

SkyEye shows end of police chase near Wichita and Almeda; 2 suspects in custody, HPD saysGeneral
SkyEye shows end of police chase near Wichita and Almeda; 2 suspects in custody, HPD says
Daniela Hurtado-5h ago-1 sources
WW International Shares Drop 16%General
WW International Shares Drop 16%
Unknown-5h ago-1 sources
Rayonier Advanced Materials Shares Fall 5% After Fire At Jesup FacilityGeneral
Rayonier Advanced Materials Shares Fall 5% After Fire At Jesup Facility
Unknown-5h ago-1 sources